InflaRx N.V. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was EUR 29.48 million compared to EUR 45.63 million a year ago. Basic loss per share from continuing operations was EUR 0.67 compared to EUR 1.1 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.68 USD | +1.20% |
|
+0.60% | +3.07% |
06-24 | Sector Update: Health Care Stocks Advance Monday Afternoon | MT |
06-24 | Sector Update: Health Care | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.07% | 98.92M | |
+20.17% | 126B | |
+24.67% | 118B | |
+25.07% | 27.87B | |
-17.74% | 20.95B | |
-15.29% | 16.92B | |
-15.21% | 16.18B | |
+11.91% | 14.84B | |
-47.10% | 14.79B | |
+54.50% | 14.08B |
- Stock Market
- Equities
- IFRX Stock
- News InflaRx N.V.
- InflaRx N.V. Reports Earnings Results for the Full Year Ended December 31, 2022